Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 2. Our second daily wrap-up features highlights from the key late breaking trials, and some of the most interesting abstracts presented at the meeting. Key Late-Breaking Clinical Trials Covered: • ROCKET-AF Trial – Rivaroxaban was compared with warfarin in patients with nonvalvular atrial fibrillation • SMART-AV Trial – Compared 3 alternative AV optimization techniques and assess whether optimization of AV delay SmartDelay Algorithm would improve heart failure • CLOSURE-I Trial – Compared safety and efficacy of STARFlex septal closure device versus best medical therapy in patients with stroke or TIA due to presumed paradoxical embolism through a PFO Highlighted in the video is expert commentary from leaders in cardiology including: • Robert M. Califf, MD – Professor of Cardiology, Vice Chancellor for Clinical Research, Director of the Duke Translational Medicine Institute • Peter R. Kowey, MD – Chief of the Division of Cardiovascular Diseases, Lankenau Hospital and the Main Line Health System • Anthony J. Furlan, MD – Chairman of Neurology, University Hospitals – Case Medical Center • James Januzzi, MD – Director, Coronary Care Unit, Massachusetts General Hospital, Associate Professor, Harvard Medical School • Kim Williams, MD – Division Chief, Cardiology, Dorothy Susan Timmis Endowed Chair in Cardiology, Department of Internal Medicine, Wayne State University School of Medicine • Michelle A. Albert, MD, MPH – Assistant Professor, Harvard Medical School Check back tomorrow for AHA Scientific Sessions Meetings in Minutes – Day 3.